Novartis says Entresto could become $5 billion a year blockbuster drug

ZURICH (Reuters) - A Novartis executive said the Swiss company's heart failure medicine Entresto could be used more widely in future, potentially making it a blockbuster drug with revenue potential of $4 billion to $5 billion a year.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news